Fig. 1. Details of the prescription for central nervous treatment
Fig. 2. Trends of the use on antipsychotic drugs in children of intellectual disabilities with hyperactivity disorder
Fig. 3. Prescription rate of antipsychotic drugs
Fig. 4. Number of days of antipsychotic prescription and multiple prescription rate of antipsychotic drug
Table 1. Analysis of J-STAGE
Table 2. The antipsychotic in high-frequency of use
Table 3. Comparison of use ratio of psychotropic drug
Table 4. Characteristic of analysis subject
참고문헌
- K M. Chitty et al. (2016). Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Aust NZJ Psychiatry, 50(4), 352-362. https://doi.org/10.1177/0004867415587951
- N. D. Goli et al. (2016). Intellectual Disability in Children; a Systematic Review. Quarterly of International Archives of Health Sciences. 3(2), 27-36. https://doi.org/10.18869/IAHS.3.2.27
- S. L. Einfeld et al. (2011). Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Disabil., 36(2), 137-143. https://doi.org/10.1080/13668250.2011.572548
- Y. H. Kang. (2008). Encyclopedia of Life Science. Academy Books.
- M. A Song & H. J. Hong. (2013). Use of Antipsychotics in Attention-Deficit Hyperactivity Disorder. Korean College of Neuropsychopharmcology, establishment 11-17.
- E. Y. Oh, et al. (2000). Comparison of Therapeutic Efficacy between Haloperidol and Risperdone in Tic Disirders. Korean College of Neuropsychopharmcology, 11(3), 270-277.
- N. Ji & R. L. Findling. (2015). Anupdate on pharmacotherapy for autism Spectrum Disorder in Children and Adolescents. Curr Opin Psychiatry, 28(2), 91-101. https://doi.org/10.1097/yco.0000000000000132
- J. S. Choi. (1993). Pharmacological Treatment in pervasive developmental disorders. J. the Korean Academy of Child and Adolescent Psychiatry. 4(1), 27-38.
- T. Hayashi et al. (2004). Actual Conditions of Use of Anti-Psychotic Drugs in Institute for People with Intellectual Disabilities. Bulletin of the School of Nursing, Yamaguchi Prefectural University, 8, 1-4.
- Y. Ono. (2000). Usage status of psychotropic medication in Mental retardation. Clinical psychiatry, 47(7), 697-703.
- H. Nakayama. (2001). A Questionnaire survey on the psychiatric conditions of patients in residential facilities for mentally handicapped children. Japanese Journal of Child and Adolescent Psychiatry. 42(1), 57-65.
- K. Tanaka et al. (2006). Clinical Characteristics and Pharmacotherapy of Extremely Disruptive Behavior Disorders in People with Mental Retardation. No To Hattatsu, 38, 19-24.
- H. J. Yu. (2018). The clinical approach of mental health to the socially underprivileged such as developmnetal disability etc. Classroon of a psychiatrist in Seoul National University, SHUBH, The psychiatry department, presentation material.
- M. S. Kim & H. J., Kim. (2011). Understand and Education of Special Children for Special Education Teacher. Changjisa. 140-146.
- D. L. Bowring et al. (2017). Challenging behaviors in adults with intellectual disability: A total poupulation study and exploration of risk indices. Br J Clin Psychol. 56(1). 16-32 https://doi.org/10.1111/bjc.12118
- J. Y. Kwon. (2009). Diagnostic Evaluation and Rehabilitation in Children with Intellectual Disabilities. Korean Med Assoc. 52(6), 601-610. https://doi.org/10.5124/jkma.2009.52.6.601
- M. Y. Choi. (2009). Health and Medical Care for People With Disability. Health And welfare Forum, 46-63.
- M, Weiss et. al. (2009). A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic. J Child Adolesc Psychopharmacol, 19, 575-582. https://doi.org/10.1089/cap.2009.0050
- S. B. Lee et. al. (2016). Differences of obstetric complications and clinical characteristics between autism spectrum disorder and Intellectual Disability. Psychosmatic, 24(2), 165-173.
- E. Y. Oh et. al. (2013). Comparison of Therapeutic Efficacy between Haloperidol and Risperidone in Tic Disorders. The Korean Journal of Psychopharmacology, 11(3), 270-277
- H. W. Sin. (2011). Recognition of the importance and practice of the assessment of rehabilitation services and therapeutic facilities for disables person. Unpublished master's dissertation, Kwangwoon University.
- H. K. Lim(2014). Social Worker's perception of minimum service standards of residental care facilities for the disabled. Unpublished master's dissertation, Ulsan University.
- S. K. Park.(2016). The present condition and tasks of deinstitutionalization of the people with disabilities in Korea. Journal of Intellectual Disabilities, 18(1), 205-234.
- Y. Inoue et al. (2016). Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities : A cohort Study Using a Large-Scale Health Insurance Database. Psychiat. neurol. Jap, 118(11), 823-833.
- Japanese Association on intellectual & Welfare Disabilities. (2016). National Intellectual Disabilities Report on actual condition of entrance facility. 235-295.
- Y. I. Chung & S. H. Park. (2006). Development History of Antipsychotic Drugs. The Korean Journal of Psychopharmacology, 17(3), 283-290.
- T. Doan et. al. (2014). Psychotropic medication use in adolescents with intellectual disability living in the community. Pharmacoepidemiol Drug Saf, 23(1), 69-76. https://doi.org/10.1002/pds.3484
- I. Kimura et. al.(2016). Treatment for self-injurious in mentally hadicapped populatons -a report from our practice. Hattatsu, 48, 117-121.
- S. W, Hsu er. al. (2014). Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007. Res Dev Disabil., 35(2), 364-372. https://doi.org/10.1016/j.ridd.2013.11.011
- J. S. Kwon & K. J. Lee. (2004). Atypical Antipsychotics : The Benefit and Disadvantage. Korean J Psychopharmacol, 15(2), 125-134.
- J. W. Park & H. Y. Im.(1993). The Experiences of Antipsychotic Agents in Mentally Disabled. Korean J Str Res, 20, 21-30.